18.54
price down icon0.11%   -0.02
after-market Dopo l'orario di chiusura: 18.00 -0.54 -2.91%
loading

Tourmaline Bio Inc Borsa (TRML) Ultime notizie

pulisher
Jul 15, 2025

Why Tourmaline Bio Inc. stock attracts strong analyst attentionDouble Your Capital Alerts - Newser

Jul 15, 2025
pulisher
Jul 15, 2025

How Tourmaline Bio Inc. stock performs during market volatilityFree Discussion Group - Newser

Jul 15, 2025
pulisher
Jul 15, 2025

What makes Tourmaline Bio Inc. stock price move sharplyCarefully Curated High Return Stocks - Newser

Jul 15, 2025
pulisher
Jul 15, 2025

How Orange County Bancorp Inc. stock performs during market volatilityDouble Profit With Half Risk - Newser

Jul 15, 2025
pulisher
Jul 15, 2025

What makes Synopsys Inc. stock price move sharplyPro Trader Stock Focus - Newser

Jul 15, 2025
pulisher
Jul 15, 2025

How KRON stock performs during market volatilityVerified Return Tips - Newser

Jul 15, 2025
pulisher
Jun 24, 2025

Graves Ophthalmopathy Market Set to Grow Substantially Through 2034, DelveInsight Projects | Novartis, AdvanceCor, Apitope, Worg Pharma, AV7 Limited - Barchart.com

Jun 24, 2025
pulisher
Jun 23, 2025

Avrupa Minerals (CVE:AVU) Trading 33.3% Higher – What’s Next? - Defense World

Jun 23, 2025
pulisher
Jun 13, 2025

Tourmaline Bio, Inc. (NASDAQ:TRML) Shares Bought by California State Teachers Retirement System - Defense World

Jun 13, 2025
pulisher
Jun 12, 2025

Cantor Fitzgerald Weighs in on Tourmaline Bio FY2026 Earnings - Defense World

Jun 12, 2025
pulisher
Jun 10, 2025

Corrigendum: THE ROLE OF IL-6 IN THYROID EYE DISEASE: AN UPDATE ON EMERGING TREATMENTS - Frontiers

Jun 10, 2025
pulisher
Jun 10, 2025

Two Sigma Investments LP Sells 21,904 Shares of Tourmaline Bio, Inc. (NASDAQ:TRML) - Defense World

Jun 10, 2025
pulisher
Jun 09, 2025

Tourmaline Bio Releases Updated Corporate Presentation - TipRanks

Jun 09, 2025
pulisher
Jun 06, 2025

Tourmaline Bio Elects Directors and Ratifies Auditor - TipRanks

Jun 06, 2025
pulisher
Jun 06, 2025

Tourmaline Bio, Inc. (NASDAQ:TRML) Shares Bought by Bank of America Corp DE - Defense World

Jun 06, 2025
pulisher
Jun 04, 2025

Nuveen Asset Management LLC Has $1.55 Million Stock Position in Tourmaline Bio, Inc. (NASDAQ:TRML) - Defense World

Jun 04, 2025
pulisher
Jun 03, 2025

BNP Paribas Financial Markets Reduces Holdings in Tourmaline Bio, Inc. (NASDAQ:TRML) - Defense World

Jun 03, 2025
pulisher
Jun 02, 2025

Jane Street Group LLC Cuts Stock Position in Tourmaline Bio, Inc. (NASDAQ:TRML) - Defense World

Jun 02, 2025
pulisher
Jun 01, 2025

MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. Has $291,000 Stake in Tourmaline Bio, Inc. (NASDAQ:TRML) - Defense World

Jun 01, 2025
pulisher
May 31, 2025

Deutsche Bank AG Grows Stock Holdings in Tourmaline Bio, Inc. (NASDAQ:TRML) - Defense World

May 31, 2025
pulisher
May 30, 2025

Tourmaline Bio, Inc. (NASDAQ:TRML) Receives Average Recommendation of “Buy” from Brokerages - Defense World

May 30, 2025
pulisher
May 29, 2025

BMO Sees Overreaction, Maintains Rating and Price Target on Tourmaline Bio (TRML) - MSN

May 29, 2025
pulisher
May 28, 2025

H.C. Wainwright Maintains Buy Rating on Tourmaline Bio (TRML) After Promising Phase 2 Results - Insider Monkey

May 28, 2025
pulisher
May 27, 2025

H.C. Wainwright maintains $50 target on Tourmaline Bio stock By Investing.com - Investing.com India

May 27, 2025
pulisher
May 27, 2025

H.C. Wainwright maintains $50 target on Tourmaline Bio stock - Investing.com

May 27, 2025
pulisher
May 27, 2025

Millennium Management LLC Has $7.40 Million Position in Tourmaline Bio, Inc. (NASDAQ:TRML) - Defense World

May 27, 2025
pulisher
May 26, 2025

Leerink Partnrs Comments on Tourmaline Bio FY2026 Earnings - Defense World

May 26, 2025
pulisher
May 25, 2025

Tourmaline Bio Shares Drop After Phase 2 Results for Obesity Drug Pacibekitug Fail to Meet Analyst Expectations - geneonline.com

May 25, 2025
pulisher
May 23, 2025

Tourmaline Bio, Inc. (NASDAQ:TRML) Stock Position Lifted by Northern Trust Corp - Defense World

May 23, 2025
pulisher
May 23, 2025

Leerink Partners Maintains Tourmaline Bio(TRML.US) With Buy Rating, Maintains Target Price $54 - 富途牛牛

May 23, 2025
pulisher
May 21, 2025

BMO maintains $35 target on Tourmaline Bio, sees overreaction - Investing.com Australia

May 21, 2025
pulisher
May 21, 2025

Tourmaline Bio stock holds $63 target post-Ph2 data By Investing.com - Investing.com Nigeria

May 21, 2025
pulisher
May 21, 2025

BMO maintains $35 target on Tourmaline Bio, sees overreaction By Investing.com - Investing.com Nigeria

May 21, 2025
pulisher
May 21, 2025

Tourmaline Bio stock holds $63 target post-Ph2 data - Investing.com

May 21, 2025
pulisher
May 21, 2025

Tourmaline shares waver as investors mull mid-stage pacibekitug data - The Pharma Letter

May 21, 2025
pulisher
May 21, 2025

In Brief: Tourmaline Reports Positive Topline Phase II Results for Pacibekitug In CKD - insights.citeline.com

May 21, 2025
pulisher
May 21, 2025

Tourmaline Bio (TRML) Shares Drop After Trial Data Release - GuruFocus

May 21, 2025
pulisher
May 20, 2025

Tourmaline Bio: TRANQUILITY Study Data Lends Credibility For IL-6 Inhibition - Seeking Alpha

May 20, 2025
pulisher
May 20, 2025

Gold Gains Over 1%; Amer Sports Posts Upbeat Earnings - Benzinga

May 20, 2025
pulisher
May 20, 2025

Tourmaline shares fall on Phase 2 data; Schrödinger cuts staff - BioPharma Dive

May 20, 2025
$21.87
price up icon 3.40%
$35.60
price down icon 2.49%
$104.59
price up icon 1.67%
$28.27
price up icon 16.05%
$112.49
price up icon 1.66%
biotechnology ONC
$279.16
price up icon 3.51%
Capitalizzazione:     |  Volume (24 ore):